Paul Hastings lands at startup aimed at cancer's 'natural killer'

Paul Hastings starts Tuesday at Nkarta Therapeutics, a South San Francisco startup focused on harnessing "natural killer" cells in the immune system to defeat cancer.

Source: bizjournals.com Health Care:Biotechnology headlines - February 20, 2018 Category: Biotechnology Authors: Ron Leuty Source Type: news